Table 3.
Burn survivors with grafted skin |
||||||
---|---|---|---|---|---|---|
17-40% BSA Grafted | >40% BSA Grafted | Control | ||||
Pre Acclimation | Post Acclimation | Pre Acclimation | Post Acclimation | Pre Acclimation | Post Acclimation | |
SNP: Maximal cutaneous vascular conductance (AU·mmHg) | 2.63±0.47 | 2.68±0.79 | 2.38±1.38 | 2.36±1.19 | 2.67±0.83 | 2.79±0.58 |
MCh: Maximal cutaneous vascular conductance (AU·mmHg) | 2.84±0.87 | 2.69±1.10 | 2.73±1.18 | 3.12±1.22 | 2.70±0.77 | 2.74±0.77 |
SNP cutaneous vascular conductance EC50 (log molar concentration) | −3.64±0.76 | −3.63±0.70 | −3.85±1.09 | −3.48±0.86 | −3.68±0.78 | −3.69±0.50 |
MCh cutaneous vascular conductance EC50 (log molar concentration) | −4.30±0.45 | −4.17±0.81 | −4.29±1.67 | −4.18±0.92 | −4.12±1.14 | −4.29±0.68 |
EC50: Concentration of the indicated drug that resulted in half the peak response. SNP: sodium nitroprusside. MCh: methacholine.